First-in-Human Study in Healthy Subjects with FR104, a Pegylated Monoclonal Antibody Fragment Antagonist of CD28-Reference-Cited by-同舟云学术

First-in-Human Study in Healthy Subjects with FR104, a Pegylated Monoclonal Antibody Fragment Antagonist of CD28

Published:2016-11-14 Issue:12 Volume:197 Page:4593-4602
ISSN:0022-1767
Container-title:The Journal of Immunology
language:en
Short-container-title:J.I.

Author:

Poirier Nicolas,Blancho Gilles,Hiance Maryvonne,Mary Caroline,Van Assche Tim^ORCID,Lempoels Jos,Ramael Steven,Wang Weirong,Thepenier Virginie,Braudeau Cecile,Salabert Nina,Josien Regis^ORCID,Anderson Ian,Gourley Ian^ORCID,Soulillou Jean-Paul,Coquoz Didier^ORCID,Vanhove Bernard

Publisher

The American Association of Immunologists

Subject

Immunology,Immunology and Allergy

Reference39 articles.

1. Abatacept for Rheumatoid Arthritis Refractory to Tumor Necrosis Factor α Inhibition

2. Abatacept in children with juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled withdrawal trial

3. Long-term safety and efficacy of abatacept in children with juvenile idiopathic arthritis

4. Five-Year Safety and Efficacy of Belatacept in Renal Transplantation

5. Ville S. Poirier N. Branchereau J. Charpy V. Pengam S. Nerriere-Daguin V. Le Bas-Bernardet S. Coulon F. Mary C. Chenouard A. . 2016. Anti-CD28 antibody and belatacept exert differential effects on mechanisms of renal allograft rejection. J. Am. Soc. Nephrol. DOI: 10.1681/ASN.2015070774.

Cited by 48 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advancing immunosuppression in liver transplantation: A narrative review;Hepatobiliary & Pancreatic Diseases International;2024-10

2. Biosensing-based quality control monitoring of the higher-order structures of therapeutic antibody domains;Analytica Chimica Acta;2024-05

3. Dendritic cell and co-stimulatory molecule targeted therapy for autoimmune diseases: a review of the newly implemented strategies;Exploration of Immunology;2024-04-02

4. Evaluation of single-strain Prevotella histicola on KLH-driven immune responses in healthy volunteers: A randomized controlled trial with EDP1815;Medicine in Microecology;2024-03

5. Siplizumab combination therapy with belatacept or abatacept broadly inhibits human T cell alloreactivity in vitro;American Journal of Transplantation;2023-10